Andrew Darlington, DO
Advanced Heart Failure and Transplant Cardiology · Fayetteville, GANPI 1942352851
Payments from drug & device makers
Across 1,353 payments — averaging $792.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$198K
- Akcea Therapeutics, Inc.$157K
- Merck$137K
- E.r. Squibb & Sons, L.L.C.$121K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$117K
- Pfizer$106K
- plus $237K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 237 | $197,878 |
| Akcea Therapeutics, Inc. | 214 | $157,385 |
| Merck | 136 | $137,092 |
| E.r. Squibb & Sons, L.L.C. | 123 | $120,675 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 128 | $116,593 |
| Pfizer | 107 | $106,108 |
| Novartis | 87 | $69,365 |
| Scpharmaceuticals Inc. | 26 | $34,881 |
| American Regent | 9 | $30,627 |
| Lexicon Pharmaceuticals, Inc. | 41 | $30,479 |
| Alnylam Pharmaceuticals Inc. | 41 | $26,080 |
| Bridgebio Pharma, Inc. | 33 | $17,897 |
| Bayer | 27 | $13,349 |
| Ionis Pharmaceuticals, Inc. | 4 | $6,985 |
| Vifor Pharma, Inc. | 2 | $2,375 |
| Boehringer Ingelheim | 16 | $1,061 |
| Medtronic | 8 | $910 |
| Actelion Pharmaceuticals US, Inc. | 36 | $820 |
| Abbott | 18 | $454 |
| Novo Nordisk | 16 | $336 |
| Cvrx, Inc. | 11 | $323 |
| Impulse Dynamics (USA) Inc. | 2 | $195 |
| Analog Devices Inc. | 3 | $153 |
| Shockwave Medical, Inc | 1 | $103 |
| Johnson & Johnson | 8 | $102 |
| Amgen | 5 | $84 |
| Amarin Pharma, Inc. | 2 | $48 |
| United Therapeutics Corporation | 2 | $48 |
| Sobi, Inc | 2 | $44 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Kls-martin L.p. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
How this compares
$1,072,610 in reported general payments places this provider in the 95th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Fayetteville
- David MarkhamFayetteville$6K
- Sushee GaddeFayetteville$5K
- Chad MaoAtlanta$1.3M
- Darshak KariaAugusta$908K
- Catherine MartiAthens$652K
- Ugochukwu EgolumGainesville$499K
- Andrew SmithAtlanta$413K
- Alanna MorrisGainesville$370K
- Abdul Latif BikakMarietta$274K
- Robert ColeAtlanta$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.